SMA Newborn Screening Study
We are conducting a number of surveys and interviews to gather views on whether Spinal Muscular Atrophy should be added to the list of conditions that newborn babies are routinely screened for in the UK (heel prick, bloodspot, or Guthrie test).
We will be looking for participants from the general public, parents who are taking part in the SMA newborn screening pilot, people with SMA and their family members, and health care professionals.
For more information please contact SMAscreening@warwick.ac.uk
Who is conducting the study?
The study is funded by Novartis.
Coming soon....Survey for parents taking part in SMA Screening Pilot
Survey to gather the views of parents who have been offered screening for SMA as part of the study “Population-based New-Born Screening of Spinal Muscular Atrophy to evaluate the uptake and feasibility in the UK context” being led by Prof Laurent Servais at Oxford University
Coming soon...Survey for members of the general public on newborn SMA screening
Survey to gather the views of members of the public on adding screening for Spinal Muscular Atrophy to existing newborn blood-spot screening
Coming soon...Survey for people with SMA and their family members
Survey to gather the views of people with Spinal Muscular Atrophy, and their family members, on adding screening for SMA to existing newborn blood-spot screening
This page will be updated with more information about the study and how to participate soon. Please contact eitheror if you have any questions about the study.